Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EKF Diagnostics Holdings ( (GB:EKF) ) has provided an announcement.
EKF Diagnostics Holdings has repurchased 100,000 of its ordinary shares at a weighted average price of 23.6 pence per share, with the stock to be held in treasury rather than cancelled. The transaction signals ongoing use of its buyback authority and leaves the company’s total issued share capital at 431,963,112 shares, of which 430,998,112 now carry voting rights, a key reference point for investors monitoring disclosure thresholds.
The buyback modestly reduces the free float and may support the share price by demonstrating management’s willingness to return capital and manage equity efficiently. Harwood Capital Management did not participate in this particular transaction, indicating no change in holdings for that significant shareholder, while the updated voting share count provides clarity for stakeholders tracking ownership changes under FCA transparency rules.
The most recent analyst rating on (GB:EKF) stock is a Hold with a £26.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.
Spark’s Take on EKF Stock
According to Spark, TipRanks’ AI Analyst, EKF is a Neutral.
The score is driven by solid financial resilience (low leverage and generally healthy cash generation) and a constructive earnings outlook (margin improvement, capacity expansion, new contracts, and buyback). These positives are tempered by weak technicals (price below major moving averages and negative MACD) and only mid-range valuation support (P/E ~15.6, no dividend yield provided).
To see Spark’s full report on EKF stock, click here.
More about EKF Diagnostics Holdings
EKF Diagnostics Holdings is an AIM-listed global diagnostics business specialising in point-of-care analysers in hematology and diabetes, as well as life sciences services that manufacture enzymes and custom products for diagnostic, food and industrial uses. Headquartered in Penarth near Cardiff, the company operates five manufacturing sites in the U.S. and Germany and sells into more than 120 countries worldwide.
Average Trading Volume: 354,589
Technical Sentiment Signal: Strong Sell
Current Market Cap: £101.7M
See more insights into EKF stock on TipRanks’ Stock Analysis page.

